LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is a mixture of bacteriophages targeting Listeria monocytogenes and permitted for use as an antimicrobial agent in specific food applications under 21 CFR 172.785 in the United States. Its use is governed by defined identity, purity, and application methods to ensure safety and specificity against the pathogen without impacting food quality. Specific international ADI values and JECFA assessments for this preparation are not available in current JECFA databases.
What It Is
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is a biologically derived antimicrobial agent composed of a defined mixture of bacteriophages that specifically target the foodborne pathogenic bacterium Listeria monocytogenes. Bacteriophages, often called phages, are naturally occurring viruses that infect and lyse specific bacterial species. In this preparation, the phages are strictly lytic, meaning they infect the bacterial cells and cause them to rupture, thereby reducing or eliminating viable L. monocytogenes present on food surfaces. This targeted approach distinguishes it from non-specific chemical preservatives and contributes to food safety while minimizing potential impacts on sensory quality. According to United States regulations under 21 CFR 172.785, this additive may be safely used in direct food applications that comply with ready-to-eat definitions to control Listeria contamination conditions of current good manufacturing practice. The regulation text describes that the preparation consists of equal proportions of six purified lytic phages specific to L. monocytogenes with defined test isolates and potency criteria. Additionally, there are specifications ensuring absence of toxin-encoding sequences and contamination with other bacteria in the preparation. The use of bacteriophage preparations such as this is an example of modern biocontrol technologies applied in food safety to reduce microbial hazards specific to public health concerns.
How It Is Made
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is produced using controlled microbiological fermentation and purification processes. The bacteriophages in the preparation are propagated in cultures of Listeria hosts under sterile conditions that support phage replication. After growth, the phage-containing lysate undergoes clarification and purification steps, such as filtration and centrifugation, to remove host cell debris and non-phage materials. The final product is standardized to achieve a predetermined phage titer, commonly on the order of 1×109 plaque forming units per milliliter for each monophage in the mixture, ensuring consistent antimicrobial activity. Regulatory specifications incorporated by reference identify analytical methods for determining both phage potency and purity. These methods help ensure the absence of residual contaminants, such as other microorganisms or genetic elements encoding toxins, that could compromise safety. Although the preparation is biological rather than a single chemical entity, strict identity and potency tests are part of regulatory compliance. The final product is typically formulated as a liquid suitable for direct application onto food surfaces in accordance with current good manufacturing practices. Because it is a mixture of lytic phages, its production does not involve introducing genetic modifications to the phages themselves; rather, it relies on natural phage biology to achieve the desired antimicrobial effect. Manufacturers following good laboratory and manufacturing practices adhere to rigorous quality control and documentation, further reinforcing safety and consistency in production.
Why It Is Used In Food
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is used in food safety management to help control contamination with the pathogenic bacterium Listeria monocytogenes, which can cause listeriosis, a serious infection particularly concerning in ready-to-eat foods that are not subsequently cooked by consumers. Pathogen control strategies in food processing often integrate multiple hurdles, including sanitation, thermal processing, and antimicrobial agents. In this context, bacteriophage preparations provide a targeted biological intervention that can be applied directly to food products or contact surfaces to reduce the prevalence of Listeria without altering the sensory or nutritional quality of the food. Their specificity means that they act only against the target pathogen and do not impact other desirable microorganisms or general food chemistry. This specificity allows processors to address a major food safety hazard while maintaining product quality and consumer acceptance. Phage-based interventions are considered part of hazard control plans and may complement other regulatory requirements or industry practices designed to reduce foodborne illness risks. Because the preparation is authorized under specific regulatory conditions of use, food manufacturers can incorporate it into their safety programs where appropriate to help meet food safety objectives related to Listeria control.
Adi Example Calculation
Because a specific numeric acceptable daily intake (ADI) is not established for LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION in international additive evaluations, a conventional ADI example calculation is not provided. For biological antimicrobial agents, regulatory assessments focus on defined use conditions, purity criteria, and evidence of specificity for target bacteria rather than deriving an ADI in mg per kg body weight. In general, when ADIs are used for chemical additives, calculations might illustrate hypothetical exposure relative to body weight; however, for this bacteriophage preparation, regulatory authorization hinges on meeting identity, potency, and safety specifications in food applications, with exposure managed through prescribed application methods and concentrations. This reflects the biological nature of the preparation and the way safety evaluations are conducted for biologically derived agents in food safety programs.
Safety And Health Research
Safety and health research related to bacteriophage preparations such as LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION emphasizes the specificity of phage activity and the absence of effects on eukaryotic cells, including human cells, due to their exclusive targeting of bacterial hosts. Scientific literature reviewing phage applications in food safety notes that phage preparations do not infect or replicate in human or animal tissues and are ubiquitous in the environment and foods, contributing to their safety profile when used as intended. Regulatory agencies assess identity, purity, and the absence of toxic contaminants as part of safety evaluations for food additive use. Because bacteriophages are biological entities, considerations include ensuring that preparations do not carry toxin-encoding sequences, genetic elements of concern, or viable bacterial contaminants. Reviews of phage biocontrol in food processing discuss both the advantages of targeted antimicrobial action and ongoing research into the ecological and risk aspects of applying phages in complex food matrices. While phages are generally recognized as safe when specified conditions of production and use are met, continued scientific scrutiny of potential risks such as horizontal gene transfer or interactions within complex microbiomes underscores the importance of robust risk assessment frameworks. Research in food safety and microbiology continues to monitor efficacy, optimal application methods, and long-term outcomes of phage use in reducing pathogens such as Listeria monocytogenes in diverse food categories. Overall, current evidence supports the safety of well-characterized and regulated phage preparations as antimicrobial agents in food safety programs.
Regulatory Status Worldwide
In the United States, LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is recognized under 21 CFR 172.785 as a permitted food additive for use as an antimicrobial agent specific to Listeria monocytogenes, subject to defined identity, potency, and application conditions of current good manufacturing practice. This explicit regulatory authorization reflects the agency assessment that the preparation can be safely used for its intended function when regulated conditions are met. The regulation text details requirements for the mixture composition, absence of certain genetic elements, and specifications ensuring that the product does not contain toxin sequences or contaminants beyond the target phages. Although specific ADI values or international INS/E-number designations are not published for this biological preparation, its regulatory acceptance in the U.S. is clear through the CFR provision. In other jurisdictions, regulatory frameworks vary. Some bacteriophage products with similar uses have received GRAS determinations or equivalent acknowledgements, recognizing their safety in defined applications, though such determinations are product and jurisdiction specific. The European Union’s evaluation processes for bacteriophage preparations have been more case-by-case, with some products assessed by food safety authorities for specific uses, and broader regulatory harmonization continues to evolve. Codex Alimentarius and JECFA maintain databases and guidelines for evaluating food additive safety broadly, but specific JECFA evaluations for phage preparations under the INPUT name are not readily accessible. As a biological antimicrobial, this preparation is subject to scientific and regulatory review in each jurisdiction where its use is considered, and manufacturers often engage with regulators to demonstrate safety, identity, and appropriate use conditions. Regulatory acceptance worldwide reflects a growing recognition of targeted biological agents as tools for enhancing food safety when backed by evidence and controlled application.
Taste And Functional Properties
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION, as a biologically derived additive, does not impart traditional sensory properties associated with flavor, aroma, or texture changes when applied correctly. Bacteriophages are viruses that target specific bacteria and, being devoid of metabolic activity outside their bacterial hosts, they interact minimally with food matrices in ways that alter sensory perception. Their functional role is antimicrobial rather than organoleptic, and they act locally at the site of potential contamination. In general, application of phage preparations at regulated levels is not associated with changes in taste, odor, appearance, or mouthfeel, which is one reason why such biological agents can be attractive in clean label strategies seeking to avoid changes in food quality. Functional considerations for use include stability under storage conditions and compatibility with processing environments. Phages in preparations are typically stable in aqueous solutions, and while they may be sensitive to extreme heat or harsh chemical conditions, within the context of current good manufacturing practice they maintain activity against their target bacteria without interfering with other food components. Their specificity for Listeria monocytogenes means that they do not disrupt the broader microbial ecology of fermented or live culture foods outside of the target species. As biological entities, their performance depends on their ability to encounter and infect the target bacteria; formulation and application protocols aim to maximize contact with potential contamination sites without altering the intrinsic qualities of the food product.
Acceptable Daily Intake Explained
The concept of acceptable daily intake (ADI) is used by food safety authorities to describe the estimated amount of a substance that can be consumed daily over a lifetime without appreciable health risk, based on toxicological data and safety assessments. For many conventional chemical additives, specific numeric ADI values are established after extensive evaluation. However, in the case of biological materials such as LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION, formal numeric ADI values are not established in major international additive databases, and specific ADI assessments for this preparation are not documented in JECFA monographs currently available. Therefore, rather than a numeric ADI, regulators rely on defined conditions of use and specifications to manage safety, coupled with evidence that phages interact only with bacterial targets and are not harmful to human cells. The regulatory status under 21 CFR 172.785 in the United States reflects an assessment that phage preparations meeting identity and purity criteria can be used safely under prescribed conditions without an explicit numeric intake limit. In practice, ADI considerations for biological agents like phage preparations focus on exposure through intended use levels and monitoring compliance with regulatory specifications, rather than calculating a daily intake threshold. This approach is consistent with regulatory evaluations that address both safety and technological function while accounting for the unique nature of phage biology in food contexts.
Comparison With Similar Additives
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION can be compared with other antimicrobial strategies used in food safety. Chemical preservatives such as organic acids, nitrites, and certain salts have broad-spectrum activity against diverse microbes but may impact sensory qualities and chemical composition; in contrast, phage preparations target specific bacteria without altering organoleptic properties. Another biological antimicrobial approach involves bacteriocins, proteinaceous compounds produced by bacteria that inhibit related species; bacteriocins may have a somewhat broader host range than phages and can be used in fermented foods. Compared to traditional sanitizers applied to equipment and surfaces, phage preparations are designed for direct food application under controlled conditions of use. While each antimicrobial type serves to reduce microbial contamination, phage preparations offer a highly specific mode of action with minimal impact on food matrices, making them complementary to other interventions in comprehensive food safety management programs.
Common Food Applications Narrative
LISTERIA-SPECIFIC BACTERIOPHAGE PREPARATION is commonly applied in food settings where control of Listeria monocytogenes is a recognized safety priority. In ready-to-eat meat and poultry products that will not receive further cooking prior to consumption, this type of preparation can be sprayed onto product surfaces or applied through other regulated methods to reduce the presence of Listeria. Because Listeria can persist in refrigerated environments and survive in some food matrices, interventions such as bacteriophage applications are integrated into comprehensive food safety plans for products like processed deli meats, sausages, and smoked fish. Similarly, this preparation may be used in other food categories susceptible to Listeria contamination, including soft cheeses, seafood, and prepackaged salads, in accordance with current good manufacturing practice and regulatory approval conditions. Industry interest in phage-based antimicrobial agents has grown as a complement to environmental sanitation and other pathogen control strategies, particularly where traditional chemical preservatives might alter product qualities or where consumer demand favors minimal changes to sensory attributes. By reducing or eliminating Listeria contamination on surfaces and product exteriors, phage preparations support hazard control points in processing lines without impacting the appearance, taste, or texture of finished products. The use of these targeted biological agents aligns with modern approaches to food safety management that emphasize risk reduction while preserving product integrity and economic value. Their adoption reflects a broader trend toward integrating biological control measures into established food processing and hazard analysis systems to protect public health and comply with food safety standards.
Safety & Regulations
FDA
- Approved: True
- Regulation: 21 CFR 172.785
EFSA
- Notes: EFSA evaluations specific to this preparation are not clearly documented in available sources
JECFA
- Notes: No specific JECFA additive evaluation for this preparation was found in available sources
Comments
Please login to leave a comment.
No comments yet. Be the first to share!